Published in Cell Differ Dev on December 02, 1990
The plasminogen activator/plasmin system. J Clin Invest (1991) 4.20
Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A (1993) 2.09
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol (2001) 1.94
Mathematical modeling of tumor-induced angiogenesis. J Math Biol (2004) 1.51
SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol (1994) 1.40
Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest (1996) 1.38
Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol (1993) 1.18
Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo. Mol Biol Cell (1995) 1.06
Plasminogen activator inhibitor-1 regulates myoendothelial junction formation. Circ Res (2010) 1.05
Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system. J Cell Biol (1997) 0.93
Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors. Clin Exp Metastasis (1999) 0.84
Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy. Invest New Drugs (1997) 0.82
In vitro and in vivo endochondral bone formation models allow identification of anti-angiogenic compounds. Am J Pathol (2003) 0.81
Expression of HIF-2alpha/EPAS1 in hepatocellular carcinoma. World J Gastroenterol (2004) 0.81
Antiangiogenic activity of rPAI-1(23) promotes vasa vasorum regression in hypercholesterolemic mice through a plasmin-dependent mechanism. Circ Res (2011) 0.81
Reduction of experimental laser-induced choroidal neovascularization by orally administered BPHA, a selective metalloproteinase inhibitor. Graefes Arch Clin Exp Ophthalmol (2003) 0.80
Methoxychlor-induced alterations in the histological expression of angiogenic factors in pituitary and uterus. J Mol Histol (2004) 0.79
No outgrowth of chondrocytes from non-digested particulated articular cartilage embedded in commercially available fibrin matrix: an in vitro study. J Orthop Surg Res (2016) 0.75
Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res (1994) 5.64
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J (2001) 4.70
Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature (1982) 4.22
IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res (1998) 3.74
Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A (1986) 3.42
Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci U S A (1998) 3.35
In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol (1983) 2.91
Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res (1996) 2.65
Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell (1985) 2.58
The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature (1994) 2.49
Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun (1992) 2.47
Heterogeneous distribution of filipin--cholesterol complexes across the cisternae of the Golgi apparatus. Proc Natl Acad Sci U S A (1981) 2.45
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci (1997) 2.28
Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun (1991) 2.25
Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res (1997) 2.17
Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A (1993) 2.09
Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci U S A (1990) 2.07
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol (1990) 2.00
Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J Cell Sci (1995) 1.98
Notch4 and Wnt-1 proteins function to regulate branching morphogenesis of mammary epithelial cells in an opposing fashion. Dev Biol (1998) 1.90
Test for malignant transformation of rat liver cells in culture: cytology, growth in soft agar, and production of plasminogen activator. J Natl Cancer Inst (1977) 1.86
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci U S A (1993) 1.84
Phalloidin-induced hyperplasia of actin filaments in rat hepatocytes. Lab Invest (1975) 1.78
Evaluation of the carcinogenicity of chemicals: a review of the Monograph Program of the International Agency for Research on Cancer (1971 to 1977). Cancer Res (1978) 1.73
Laminin and beta1 integrins are crucial for normal mammary gland development in the mouse. Dev Biol (1999) 1.70
Respiratory tract carcinogenesis in hamsters induced by different numbers of administrations of benzo(a)pyrene and ferric oxide. Cancer Res (1972) 1.67
Absence of filipin-sterol complexes from large coated pits on the surface of culture cells. Proc Natl Acad Sci U S A (1979) 1.67
Tissue-mediated mutagenicity of vinylidene chloride and 2-chlorobutadiene in Salmonella typhimurium. Nature (1975) 1.66
Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine (1999) 1.65
Experimental cancer of the lung. Inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumors. Cancer (1967) 1.61
Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res (1997) 1.58
Human, rat and mouse liver-mediated mutagenicity of vinyl chloride in S. typhimurium strains. Int J Cancer (1975) 1.53
In vivo assembly of tight junctions in fetal rat liver. J Cell Biol (1975) 1.53
Liver-microsome-mediated formation of alkylating agents from vinyl bromide and vinyl chloride. Biochem Biophys Res Commun (1975) 1.52
Relevance of nitrosamines to human cancer. Carcinogenesis (1984) 1.51
TGF-beta 1 influences the relative development of the exocrine and endocrine pancreas in vitro. Development (1994) 1.51
IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer. Hum Mutat (1999) 1.48
Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol Chem (1992) 1.47
Human endothelial cell cultures: phenotypic modulation by leukocyte interleukins. J Cell Physiol (1985) 1.45
Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp Cell Res (1993) 1.45
Methylated purines in the deoxyribonucleic acid of various Syrian-golden-hamster tissues after administration of a hepatocarcinogenic dose of dimethylnitrosamine. Biochem J (1976) 1.35
Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol (1987) 1.35
Production of epithelial and mesenchymal tumours with rat liver cells transformed in vitro. Int J Cancer (1975) 1.33
Collagen matrix promotes reorganization of pancreatic endocrine cell monolayers into islet-like organoids. J Cell Biol (1983) 1.33
Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res (1991) 1.32
Potential risk for dengue hemorrhagic fever: the isolation of serotype dengue-3 in Mexico. Emerg Infect Dis (1996) 1.31
Repair of O-alkylpyrimidines in mammalian cells: a present consensus. Proc Natl Acad Sci U S A (1988) 1.30
Phorbol esters induce angiogenesis in vitro from large-vessel endothelial cells. J Cell Physiol (1987) 1.30
An antisense oligonucleotide to the notch ligand jagged enhances fibroblast growth factor-induced angiogenesis in vitro. J Biol Chem (1996) 1.30
Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr (1995) 1.27
Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. Cancer Res (1990) 1.24
Expression of an activated Notch4(int-3) oncoprotein disrupts morphogenesis and induces an invasive phenotype in mammary epithelial cells in vitro. Int J Cancer (2000) 1.23
Mutagenicity of vinyl chloride, chloroethyleneoxide, chloroacetaldehyde and chloroethanol. Biochem Biophys Res Commun (1975) 1.23
Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. J Natl Cancer Inst (2000) 1.23
Leukocyte interleukins induce cultured endothelial cells to produce a highly organized, glycosaminoglycan-rich pericellular matrix. J Cell Biol (1984) 1.23
Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev (1993) 1.21
Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis. Mol Cell (2001) 1.21
Effect of chronic treatment of rats with dimethylnitrosamine on the removal of O6-methylguanine from DNA. Cancer Res (1980) 1.19
Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol (1993) 1.18
Workshop on DNA repair. Mutat Res (1992) 1.18
O(6)-methyldeoxyguanosine in oesophageal DNA among individuals at high risk of oesophageal cancer. Int J Cancer (1985) 1.17
Respiratory tract carcinogenesis induced in hamsters by different dose levels of benzo-(a)pyrene and ferric oxide. J Natl Cancer Inst (1972) 1.16
Aflatoxin-albumin adducts in human sera from different regions of the world. Carcinogenesis (1990) 1.15
Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. Trans R Soc Trop Med Hyg (1992) 1.15
Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers. Cancer Res (1988) 1.14
Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats. Carcinogenesis (1986) 1.14
Inactivation of the p53 protein in cell lines derived from human esophageal cancers. Int J Cancer (1997) 1.13
Opposite polarity of filipin-induced deformations in the membrane of condensing vacuoles and zymogen granules. Science (1980) 1.13
Alkylation of DNA and tissue specificity in nitrosamine carcinogenesis. J Supramol Struct Cell Biochem (1981) 1.11
Malignant transformation in vitro of rat liver cells by dimethylnitrosamine and N-methyl-N'-nitro-N-nitrosoguanidine. Br J Cancer (1973) 1.11
Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev (1993) 1.09
Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein (1996) 1.09
p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis (1994) 1.09
Carcinogenicity of dimethylnitrosamine in Swiss mice. Br J Cancer (1966) 1.09
The predictive value of mouse liver tumour induction in carcinogenicity testing--a literature survey. Int J Cancer (1973) 1.08
Presence of an EcoRI RFLP of the c-mos locus in normal and tumor tissue of esophageal cancer patients. Nucleic Acids Res (1986) 1.08
Aflatoxin, liver enzymes, and hepatitis B virus infection in Gambian children. Cancer Epidemiol Biomarkers Prev (1994) 1.08
In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Exp Cell Res (1994) 1.06
Increased excision of O6-methylguanine from rat liver DNA after chronic administration of dimethylnitrosamine. Cancer Res (1979) 1.06
Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells. Exp Cell Res (2001) 1.05
Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas. Clin Cancer Res (2000) 1.04
Coupling and connexin 43 expression in microvascular and large vessel endothelial cells. Am J Physiol (1992) 1.04
Particle aggregates in plasma and intracellular membranes of toad bladder (granular cell). Experientia (1977) 1.03
Aflatoxin M1 in human breast milk from The Gambia, west Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC. Carcinogenesis (1992) 1.02
In vitro metabolism and microsome-mediated mutagenicity of dialkylnitrosamines in rat, hamster, and mouse tissues. Cancer Res (1975) 1.02
Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Mol Carcinog (1993) 1.01
Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Lett (2001) 1.01
Metabolism of diethylnitrosamine by human liver slices in vitro. Nature (1970) 1.01
Removal of O6-methylguanine from DNA by human liver fractions. Proc Natl Acad Sci U S A (1982) 1.01
Inhomogeneous distribution of filipin-sterol complexes in the ciliary membrane of rat tracheal epithelium. Am J Anat (1979) 1.00
p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand. Int J Cancer (1993) 1.00
Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia. Am J Pathol (2001) 1.00
Plasminogen activator inhibitor-1 is induced in migrating endothelial cells. J Cell Physiol (1992) 0.99
Phytoestrogens and inhibition of angiogenesis. Baillieres Clin Endocrinol Metab (1998) 0.99
Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution. Dev Dyn (2000) 0.99
Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems. Mutat Res (1980) 0.98
Inhomogeneous distribution of filipin-sterol complexes in smooth muscle cell plasma membrane. Nature (1979) 0.98